KVUE
Status-Quo-PlayerKenvue
$17.26
-0.63%
as of 13 Apr
Power Core
Kenvue's moat is the compounding effect of healthcare-adjacent brand trust across categories where consumers conflate familiarity with clinical credibility.
Direction of Movement
Stable Absolute Position Masking Relative Competitive Erosion
ROC 200
-20.8%
KVUE
Kenvue
$17.26
-0.63%
as of 13 Apr
DCF Fair Value: $32.38
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
Kenvue Inc. is the world's largest pure-play consumer health company, specializing in science-backed products for everyday care needs. It operates through three key segments: Self Care, offering cough, cold, allergy, pain, digestive health, smoking cessation, and eye care under brands like Tylenol, Motrin, Benadryl, Nicorette, and Zyrtec; Skin Health and Beauty, providing face, body, hair, sun, and other care items via Neutrogena, Aveeno, Rogaine, and OGX; and Essential Health, delivering oral, baby, women's health, wound care, and related products through Listerine, Johnson's, Band-Aid, and Stayfree. Kenvue serves consumers in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, focusing on trusted, iconic brands that support daily rituals and critical moments with innovation rooted in clinical research and consumer insights. Incorporated in 2022 and headquartered in Summit, New Jersey, Kenvue emphasizes integrity, quality, and solutions endorsed by healthcare professionals across diverse categories like pain relief, skin care, and oral health.
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
21,780
Website
https://www.kenvue.com